This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 1993.
Company Filing History:
Years Active: 1993
Title: The Innovative Contributions of Timothy Bill
Introduction
Timothy Bill is a notable inventor based in Williamsburg, VA (US). He has made significant contributions to the field of chemistry, particularly in the area of natural products. His work has led to advancements that are beneficial in various applications.
Latest Patents
Timothy Bill holds a patent for a process titled "Process for converting the 13-.alpha.-hydroxy group of avermectin." This innovative method involves inverting the natural stereochemistry at the 13-position of avermectin aglycones. The procedure begins with the activation of the 13.alpha.-hydroxy group to a mesylate leaving group. The resultant 13-.alpha.-mesylate is then displaced with a cesium carboxylate and one equivalent of the respective carboxylic acid. This process culminates in the conversion of the ester group to the 13-.beta.-hydroxy configuration through transesterification, achieving high yield.
Career Highlights
Timothy Bill is currently employed at Merck & Co., Inc., where he continues to apply his expertise in the field. His work at Merck has allowed him to collaborate with other talented professionals, enhancing the innovative environment of the company.
Collaborations
Some of Timothy's coworkers include Sheo B Singh and Chris H Senanayake. Their collaborative efforts contribute to the ongoing research and development initiatives at Merck.
Conclusion
Timothy Bill's contributions to the field of chemistry, particularly through his patent on avermectin, highlight his innovative spirit and dedication to advancing scientific knowledge. His work continues to impact the industry positively.